High LDL, not statin use, linked to prostate cancer recurrence

June 2013
Reactions Weekly;6/22/2013, Issue 1458, p2
The article discusses a study presented in the annual meeting of the American Urological Association in May 2013 which suggests an association between elevated levels of low density lipoprotein (LDL) and recurrence of prostate cancer after surgical treatment or radiotherapy.


Related Articles

  • Medical oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS59 

    Presents an abstract of the research manuscript `Tumor burden and increased LDL receptor expression by tumor cells may underlie progressive hypocholesterolemia in patients with advanced prostate cancer,' by A. Thibault et al.

  • Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Li, Z. G.; Yang, J.; Vazquez, E. S.; Rose, D.; Vakar-Lopez, F.; Mathew, P.; Lopez, A.; Logothetis, C. J.; Lin, S.-H.; Navone, N. M. // Oncogene;1/24/2008, Vol. 27 Issue 5, p596 

    The tendency of prostate cancer to produce osteoblastic bone metastases suggests that cancer cells and osteoblasts interact in ways that contribute to cancer progression. To identify factors that mediate these interactions, we compared gene expression patterns between two bone-derived prostate...

  • "Bad" cholesterol levels on the decline.  // Clinical Advisor;Jan2010, Vol. 13 Issue 1, p9 

    The article reports on the decline for people with high levels of low-density lipoprotein (LDL) age 20 years and older from 1999 to 2006 with the use of cholesterol analysis in the U.S. The researchers believe that the decline on the prevalence of the high LDL levels is due to the use of the...

  • Lycopene: a logical supplement for prostate problems. Challem, Jack // Natural Foods Merchandiser;Mar2008, Vol. 29 Issue 3, p116 

    The article provides information on the therapeutic use of lycopene. According to the author, lycopene is the antioxidant carotenoid that gives tomatoes their red color. Meanwhile, the article also mentions several studies that focused on the role of lycopene supplements in reducing the size of...

  • Hypofractionation therapy as effective as standard therapy for decreasing prostate cancer recurrence risk. Haigh, Christen // Hem/Onc Today;12/10/2009, Vol. 10 Issue 23, p35 

    The article discusses interim findings from a randomized trial which showed the safety and efficacy of hypofractionation therapy in reducing the risk for disease recurence in patients with prostate cancer, presented by Alan Pollack at the 51st Annual Meeting of the American Society for...

  • Positive margins don't predict recurrence in localized PCa. Bankhead, Charles // Urology Times;Dec98, Vol. 26 Issue 12, p4 

    Discusses issues pertaining to the recurrence of prostate cancer in men. Comparison of recurrence rates in patients who had positive surgical margins versus organ- or specimen-confined disease; Percentage of recurrence five years and ten years post surgery; Contributing factors to higher rates...

  • Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer. Sagalowsky, Arthur I. // AUANews;May2010, Vol. 15 Issue 5, p12 

    The article discusses potential cardiovascular risks associated with androgen deprivation therapy (ADT) in patients afflicted with prostate cancer. It lists the current uses of ADT for prostate cancer including the treatment of overt metastatic disease. It also reveals that ADT is related with...

  • Blood lipid levels and prostate cancer risk; a cohort study. Kok, D E G; van Roermund, J G H; Aben, K K H; den Heijer, M; Swinkels, D W; Kampman, E; Kiemeney, L A L M // Prostate Cancer & Prostatic Diseases;2011, Vol. 14 Issue 4, p340 

    It has been hypothesized that blood lipid levels might be associated with prostate cancer risk. The aim of the present study was to evaluate the association between serum total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and...

  • Statin benefits keep on growing.  // Cortlandt Forum;Mar2007, Vol. 20 Issue 3, p13 

    The article presents two studies which identify the substantial benefits of statins. In the first, researchers discovered that when statins decreased low density lipoproteins (LDL) and raised high density lipoproteins (HDL) by at least 7.5 percent patients experienced decrease in atheroma...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics